MedTrace Logo

Is Primiparity a Risk Factor for Neonatal Hyperbilirubinemia?

NCT03329040 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4369

Last updated 2018-09-21

No results posted yet for this study

Summary

Neonatal hyperbilirubinemia elongates hospital stay and may require treatment. The investigators noticed that bilirubin levels were higher among infants of primipara mothers than among multipara mothers. As this data is dichotomic and easy to produce, and may influence the maintenance, the investigators decided to find out if primiparity is a risk factor for neonatal hyperbilirubinemia. The investigators intend to collect data from patient files during one year, and compare the bilirubin levels and length of stay between newborns to primipara mothers and multipara mothers.

Conditions

  • Hyperbilirubinemia, Neonatal

Interventions

OTHER

No Intervention.

No intervention.

Sponsors & Collaborators

  • Hillel Yaffe Medical Center

    lead OTHER_GOV

Principal Investigators

  • Erez Nadir, MD · Hillel Yaffe Medical Center

Eligibility

Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-09-20
Completion
2018-09-20

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03329040 on ClinicalTrials.gov